Purchase Order 19GG8025P0232
Award Date
3/20/25
Potential Completion Date
3/19/26
Potential Value
$120K
Funding Federal Agency
Defense Health Agency
Contracting Federal Agency
US Embassy Tbilisi
Awardee
Elta 90 Medical Genetics LLC
Ultimate Awardee
Not listed
PSC Category
J065 - Maint/Repair/Rebuild Of Equipment- Medical, Dental, And Veterinary Equipment And Supplies
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Georgia
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Other Statutory Authority
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Health Agency awarded a $30,890 firm-fixed-price delivery order to Elta 90 Medical Genetics LLC, a small business joint venture, for the supply of MISEQ REAGENT KIT V2 500 CYCLE. This award is part of a single-award Indefinite Delivery Contract (IDC) held by Elta 90 Medical Genetics LLC with the Defense Health Agency, with a ceiling value of $688,126 and an ultimate completion date of December 31, 2027. The IDC is for the procurement of MINISEQ DEVICE, indicating that Elta 90 Medical...
Elta 90 Medical Genetics LLC has been awarded a $122,000 firm fixed price purchase order by the Defense Advanced Research Projects Agency (DARPA) to provide WRAIR_ILLUMINA MISEQ services. The contract has a period of performance from August 17, 2023 through September 30, 2023, with work to be conducted in Gürcistan. DARPA's high-level programs involve advancing technologies with potential military applications, suggesting this contract supports research using next-generation DNA sequencing...
This is a firm fixed-price Blanket Purchase Agreement (BPA) call contract awarded by the Defense Health Agency (DHA) to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The contract, valued at $581,761.93, is for the provision of support plans and reagent kits for the NextSeq equipment located at the Walter Reed Army Institute of Research (WRAIR) facility in Silver Spring, Maryland. The contract has an ultimate completion date of October 1, 2024....
The Defense Health Agency awarded a firm-fixed-price purchase order to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables, for the delivery of a genetic analyzer. The $494,929.40 contract has a completion date of September 30, 2021 and does not utilize any set-aside designations. Life Technologies Corporation, a division of Thermo Fisher Scientific, has provided similar products and services to various federal agencies, including the NIH, DoD,...
This is a firm fixed-price delivery order contract awarded by the Defense Health Agency to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables. The contract, which did not utilize a set-aside, has a total potential value of $119,130.63 and covers the period from October 1, 2018 to June 19, 2019. Life Technologies, as a prime contractor, will provide the Defense Health Agency with a range of products and services to support biomedical research,...
This is a firm fixed-price purchase order contract awarded by the U.S. Army Medical Command (MEDCOM) to Illumina, Inc., a manufacturer of sequencing and analytical instrumentation and reagents. The contract, valued at $95,931.00, is for the procurement of an SY-410-1003 ASSY, TLA, MISEQ2 item. The contract has no set-aside designation and is intended to support Illumina's provision of sequencing systems, reagents, and services to MEDCOM and its research activities. Illumina has a history of...
The Defense Health Agency, a component of the Department of Defense, awarded a $672,403 firm fixed price blanket purchase agreement call contract to Verogen, Inc. for MISEQ reagent kits. Verogen will deliver the reagent kits to support next generation sequencing under the contract, which runs from July 2, 2021 through September 28, 2021 and was awarded without any set aside designation. As the DHA works to advance genomic medicine for military service members, families, and veterans, this...
This federal contract award was issued by the Defense Health Agency (DHA) to Edge Biosystems Inc., a for-profit manufacturer of laboratory supplies and DNA sequencing products. The contract, valued at $98,280.00, is for the delivery of Performa DTR Ultra 96-well plate kits. This is a firm fixed-price delivery order contract with no set-aside designation. The contract award is associated with a larger Blanket Purchase Agreement (BPA) between Edge Biosystems Inc. and the DHA, valued at $4.5...
The Defense Health Agency awarded a $915,592.69 firm-fixed-price delivery order contract to Life Technologies Corporation, a for-profit manufacturer of scientific instruments, reagents, and consumables, for the AMPFLSTR MINIFILER product. The contract does not have a set-aside designation. Life Technologies Corporation is a division of the parent company Thermo Electron Corporation, which has a history of providing equipment maintenance, scientific instruments, and consumables as a prime...
This is a firm fixed price purchase order contract awarded by the U.S. Army Medical Command (MEDCOM) to Illumina, Inc., a manufacturer of genomic sequencing instruments and reagents. The contract, valued at $680,732.58, is for the delivery of a MiSeq FGx Sequencing System, which supports genetic and genomic analysis. The contract has no set-aside designation. Illumina has a history of providing sequencing systems and related goods and services to various federal agencies such as the National...